DAVID P PERRY

CIK 1105941 · Executive Chairman · last filed 2024-01-10

DAVID P PERRY is an Executive Chairman who has filed 19 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing shows the insider was granted $250.0K of BTTX on Jan 10, 2024. Across all open-market trades the lifetime net is +$11.0M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

19

Lifetime Open-Market Net

$11.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Better Therapeutics, Inc. (BTTX) Delisted Executive Chairman 14,607,132 $0.04 $651.5K $14.33M 8 2024-01-10
EVLO Director $0.00 $0 3 2021-06-11
Anacor Pharmaceuticals, Inc. (ANAC) Delisted President and CEO 361,306 $10.19 $3.68M -$3.29M 8 2014-03-06

Recent Filings

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-10 Better Therapeutics, Inc. (BTTX) Delisted Grant (A) +1,471,453 $250.0K EDGAR
2023-12-20 Better Therapeutics, Inc. (BTTX) Delisted Grant (A) +3,750 $0 EDGAR
2023-07-31 Better Therapeutics, Inc. (BTTX) Delisted Buy (P) +1,233,045 $900.0K EDGAR
2023-06-09 Better Therapeutics, Inc. (BTTX) Delisted Grant (A) $0 EDGAR
2023-04-12 Better Therapeutics, Inc. (BTTX) Delisted Buy (P) +9,939,394 $8.20M EDGAR
2022-09-19 Better Therapeutics, Inc. (BTTX) Delisted Buy (P) +100,000 $205.2K EDGAR
2022-06-10 Better Therapeutics, Inc. (BTTX) Delisted Grant (A) $0 EDGAR
2021-11-01 Better Therapeutics, Inc. (BTTX) Delisted Mixed +21,660,074 $7.02M EDGAR
2021-06-11 EVLO Grant (A) $0 EDGAR
2020-06-18 EVLO Grant (A) $0 EDGAR
Showing 110 of 19
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.